Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Karyopharm Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Global Secular Trends Will Drive Adoption Of Targeted Oncology Therapies
Key Takeaways Breakthrough clinical outcomes and wide physician interest could drive substantially higher adoption and long-term revenue growth than current expectations. Expansion into biomarker-driven and underserved oncology markets creates potential for major new revenue streams and attractiveness for strategic partnerships or acquisitions.
View narrative
US$66.25
FV
91.6% undervalued
intrinsic discount
34.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
OptimizeRx
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Digital Health Adoption And AI Will Drive Secular Expansion
Key Takeaways Rapid scaling of high-margin subscription offerings and AI-driven tools is positioning the company for outsized, sustained profitability with expanding margins. Strong market embedment and financial discipline create flexibility for strategic acquisitions and innovation, supporting long-term growth above industry averages.
View narrative
US$27.00
FV
37.1% undervalued
intrinsic discount
12.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
GrowGeneration
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Cannabis Legalization And Global E-Commerce Will Expand Cultivation Supply Markets
Key Takeaways Proprietary product growth and accelerated digital platform adoption could rapidly enhance profitability and outpace competitor performance. Strategic acquisitions and international expansion offer diversification, access to emerging markets, and potential for substantial long-term revenue gains.
View narrative
US$2.50
FV
37.2% undervalued
intrinsic discount
-3.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ModivCare
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Aging Population And Digital Platforms Will Transform Care Delivery
Key Takeaways Accelerating adoption of AI and integrated digital services is expected to dramatically improve efficiency, margins, and long-term profitability across all operational segments. Strategic divestitures, bundled offerings, and a leadership position in value-based, home-centered care are positioned to unlock significant competitive advantages and capital allocation opportunities.
View narrative
US$2.75
FV
11.6% undervalued
intrinsic discount
0.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Creo Medical Group
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Advanced Energy Platforms Will Boost Secular Demand In Healthcare
Key Takeaways Rapid adoption of advanced products and strategic partnerships, especially in new markets like China, set up Creo for outsized growth and improved profitability beyond current expectations. Expanding clinical data, leaner operations, and strong product launches position Creo to quickly shape industry standards and achieve sustainable, self-funded profitability ahead of consensus.
View narrative
UK£1.02
FV
86.4% undervalued
intrinsic discount
80.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Transgene
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Accelerated Aging And Healthcare Reforms Will Spark Immunotherapy Breakthroughs
Key Takeaways Accelerated trial success and regulatory pathways could lead to earlier revenue, with large pharma partnerships boosting near-term financial stability. Expanding pipeline and partnerships, driven by aging demographics and innovative technology, position Transgene for transformative, recurring revenue growth and higher margins.
View narrative
€2.60
FV
60.4% undervalued
intrinsic discount
100.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
FAT Brands
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Urbanization And Digital Ordering Will Expand Global Dining Options
Key Takeaways Aggressive cost savings, operational focus, and executive leadership could drive accelerated earnings and cash flow improvement beyond current expectations. Expansion into digital channels and international markets, plus better facility utilization, positions the company for sustained revenue and margin growth.
View narrative
US$15.00
FV
86.6% undervalued
intrinsic discount
7.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Red Robin Gourmet Burgers
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Urban Sprawl And Digital Delivery Will Invigorate Casual Dining
Key Takeaways Enhanced technology adoption and targeted marketing are set to amplify guest traffic, digital sales, and margin gains beyond what the market currently anticipates. Franchisee alignment and remodel initiatives can accelerate expansion, brand reach, and financial strength, surpassing industry expectations for growth and profitability.
View narrative
US$15.00
FV
55.5% undervalued
intrinsic discount
-3.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
PRPL
Purple Innovation
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
E-Commerce And Health Trends Will Fuel Premium Sleep Demand
Key Takeaways Outperformance in new product launches, premium mix, and alternative channels suggests revenue and margin growth above expectations, enhanced by proprietary technology and targeted distribution strategies. Strategic focus on digital transformation and omnichannel initiatives could accelerate high-margin DTC sales, strengthen pricing power, and improve long-term profitability.
View narrative
US$5.00
FV
77.6% undervalued
intrinsic discount
9.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies